| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 5,193 | 4,023 | 5,148 | 6,126 | | Cost of Revenue | 3,636 | 3,617 | 3,354 | 3,913 | | | Gross Profit | 1,557 | 406 | 1,794 | 2,213 | | | Operating Expenses | | Research Development | 1,594 | 1,306 | 1,018 | 1,298 | | Selling General and Administrative | 2,163 | 2,212 | 1,917 | 2,673 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,200) | (3,112) | (1,141) | (1,758) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11 | 28 | 49 | 63 | | Earnings Before Interest And Taxes | (2,189) | (3,084) | (1,092) | (1,695) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (2,189) | (3,084) | (1,092) | (1,695) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,189) | (3,084) | (1,092) | (1,695) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,189) | (3,084) | (1,092) | (1,695) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,189) | ($3,084) | ($1,092) | ($1,695) |
|
0.31% Nasdaq 
0.05%
Income Statement
